FDA to take 10 months to approve Oxycodone: Glenmark

Glenmark Generics had recently announced new drug application (NDA) for its drug Oxycodone Hydrochloride capsules and liquid solutions, which was submitted by their partner Lehigh Valley Technologies (LVT) to the US Food and Drug Administration (FDA).

Read more ›